Invention Grant
US08435745B2 Methods of using IL-31 antagonists in diseases mediated by cutaneous lymphocyte antigen positive T cells
有权
在皮肤淋巴细胞抗原阳性T细胞介导的疾病中使用IL-31拮抗剂的方法
- Patent Title: Methods of using IL-31 antagonists in diseases mediated by cutaneous lymphocyte antigen positive T cells
- Patent Title (中): 在皮肤淋巴细胞抗原阳性T细胞介导的疾病中使用IL-31拮抗剂的方法
-
Application No.: US12727912Application Date: 2010-03-19
-
Publication No.: US08435745B2Publication Date: 2013-05-07
- Inventor: Janine M. Bilsborough , Jane A. Gross
- Applicant: Janine M. Bilsborough , Jane A. Gross
- Applicant Address: US WA Seattle
- Assignee: ZymoGenetics, Inc.
- Current Assignee: ZymoGenetics, Inc.
- Current Assignee Address: US WA Seattle
- Agent Brian J. Walsh; Robyn Adams
- Main IPC: G01N33/00
- IPC: G01N33/00 ; G01N33/53
Abstract:
The present invention relates to predicting therapeutic response of treating patients suffering from itching and puritis mediated by cutaneous lymphocyte antigen positive T cells in atopic dermatitis. The invention also includes methods of predicting a therapeutically responsive patient population.
Public/Granted literature
- US20100266600A1 METHODS OF USING IL-31 ANTAGONISTS IN DISEASES MEDIATED BY CUTANEOUS LYMPHOCYTE ANTIGEN POSITIVE T CELLS Public/Granted day:2010-10-21
Information query
